Quarterly report pursuant to Section 13 or 15(d)

NOTE 3 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)

v3.7.0.1
NOTE 3 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($)
3 Months Ended
Mar. 31, 2017
Mar. 31, 2016
Dec. 31, 2016
Accounting Policies [Abstract]      
Research and Development Expense (in Dollars) $ 1,338,604 $ 372,426  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number 8,245,190   8,245,190
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number 7,200,928   7,028,639